These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28042572)

  • 1. Lamotrigine Reduces Inflammatory Response and Ameliorates Executive Function Deterioration in an Alzheimer's-Like Mouse Model.
    Wang K; Fernandez-Escobar A; Han S; Zhu P; Wang JH; Sun Y
    Biomed Res Int; 2016; 2016():7810196. PubMed ID: 28042572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine attenuates recognition memory impairment and hippocampal oxidative stress in a transgenic mouse model of Alzheimer's disease.
    Luo G; Liu M; He J; Guo H; Xue M; Wang X; Li XM
    Neuroreport; 2014 Jun; 25(9):647-50. PubMed ID: 24642954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
    Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
    Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.
    Xie K; Liu Y; Hao W; Walter S; Penke B; Hartmann T; Schachner M; Fassbender K
    Neurobiol Aging; 2013 Oct; 34(10):2389-98. PubMed ID: 23673309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease.
    Serrano J; Fernández AP; Martínez-Murillo R; Martínez A
    Oncogene; 2010 Apr; 29(15):2165-71. PubMed ID: 20101216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
    Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM
    J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease.
    Fu AL; Zhou CY; Chen X
    Neuropharmacology; 2010; 58(4-5):722-9. PubMed ID: 20045708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Yu D; Tao BB; Yang YY; Du LS; Yang SS; He XJ; Zhu YW; Yan JK; Yang Q
    J Alzheimers Dis; 2015; 43(1):291-302. PubMed ID: 25079795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease.
    Taylor JM; Minter MR; Newman AG; Zhang M; Adlard PA; Crack PJ
    Neurobiol Aging; 2014 May; 35(5):1012-23. PubMed ID: 24262201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial.
    Suzuki H; Gen K
    Psychogeriatrics; 2015 Mar; 15(1):32-7. PubMed ID: 25516380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
    Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
    Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    Verma M; Beaulieu-Abdelahad D; Ait-Ghezala G; Li R; Crawford F; Mullan M; Paris D
    PLoS One; 2015; 10(5):e0128224. PubMed ID: 26010758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD.
    Wang Q; Xiao B; Cui S; Song H; Qian Y; Dong L; An H; Cui Y; Zhang W; He Y; Zhang J; Yang J; Zhang F; Hu G; Gong X; Yan Z; Zheng Y; Wang X
    Dis Model Mech; 2014 Dec; 7(12):1385-95. PubMed ID: 25481013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.